Omnibus Transportation Employee Testing Act of 1991, Pub L No. 102-143, 105 Stat 952 (1991).
Chandler v Miller , 520 US 305 (1997).
NJ Transit PBA Local 304 v NJ Transit Corp , 151 NJ Sup Ct 531 (1997).
Customs Service Employees, Treasury Employees v Von Raab , 489 US 656 (1989).
Vernonia School District 47J v Acton , 515 US 646 (1995).
Skinner v Railway Labor Executives Assn , 489 US 602 (1989).
Catrou PG, Khazanie P. Limited toxicology screening: end of a controversy. Am J Clin Pathol.1996;105:527-528.
Bailey DN. Results of limited versus comprehensive toxicology screening in a university
medical center. Am J Clin Pathol.1996;105:572-575.
Meatherall R, Dai J. False-positive EMIT II opiates from ofloxacin. Ther Drug Monit.1997;19:98-99.
National Committee of Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility
Testing: 7th International Supplement. Wayne, Pa: National Committee of Clinical Laboratory Standards; 1997.
Paul BD, Shimomura ET, Smith ML. A practical approach to determine cutoff concentrations for opiate
testing with simultaneous detection of codeine, morphine, and 6-acetylmorphine
in urine. Clin Chem.1999;45:510-519.
Mandatory guidelines for federal workplace drug testing programs, 53 Federal Register.11 979 (1988).
Changes to the testing cutoff levels for opiates for federal workplace
drug testing programs. 60 Federal Register.57 587 (1995).
Manadatory guidelines for federal workplace drug testing programs. 62 Federal Register.51 118 (1997).
Andriole V. The Quinolones. Orlando, Fla: Academic Press Inc; 1998.
Borner K, Borner E, Lode H. A metabolite of sparfloxacin in urine. Drugs.1993;45(suppl 3):303-304.
Bron NJ, Dorr MB, Mant TG, Webb CL, Vassos AB. The tolerance and pharmacokinetics of clinafloxacin (CI-960) in healthy
subjects. J Antimicrob Chemother.1996;38:1023-1029.
Chien SC, Chow AT, Natarajan J.
et al. Absence of age and gender effects on the pharmacokinetics of a single
500 mg oral dose of levofloxacin in healthy subjects. Antimicrob Agents Chemother.1997;41:1562-1565.
Guibert J, Kitzis MD, Brumpt I, Acar JF. Antibacterial activity of pefloxacin in the urine during seven days
after a single 800 mg oral dose [in French]. Pathol Biol (Paris).1989;37:406-410.
Hoffken G, Lode H, Prinzing C, Borner K, Koeppe P. Pharmacokinetics of ciprofloxacin after oral and parenteral administration. Antimicrob Agents Chemother.1985;27:375-379.
Monk J, Campoli-Richards DM. Ofloxacin: a review of its antibacterial activity, pharmacokinetic
properties and therapeutic use. Drugs.1987;33:346-391.
Montay G, Goueffon Y, Roquet F. Absorption, distribution, metabolic fate, and elimination of pefloxacin
mesylate in mice, rats, dogs, monkeys, and humans. Antimicrob Agents Chemother.1984;25:463-472.
Nakashima M, Uematsu T, Kosuge K.
et al. Single- and multiple-dose phamacokinetics of AM-1155, a new 6-fluro-8-methoxy
quinolone, in humans. Antimicrob Agents Chemother.1995;39:2635-2640.
Wise R, Lockley R, Dent J, Webberly M. Pharamacokinetics and tissue penetration of enoxacin. Antimicrob Agents Chemother.1984;26:17-19.
Wise R, Andrews JM, Marshall G, Hartman G. Pharmacokinetics and inflammatory-fluid penetration of moxifloxacin
following oral or intravenous administration. Antimicrob Agents Chemother.1999;43:1508-1510.
Gjerde H, Christophersen AS, Skuterud B, Klemetsen K, Morland J. Screening for drugs in forensic blood samples using EMIT urine assays. Forensic Sci Int.1990;44:179-185.
Salerno C, Wisniewski HM, Raoul RD. Effect of poppy seed ingestion on the TDx opiates assay. Ther Drug Monit.1990;12:210-211.
Selavka C. Poppy seed ingestion as a contributing factor to opiate-positive urinalysis
results: the Pacific perspective. J Forensic Sci.1991;36:685-696.
Pettitt BC, Dyszel SM, Hood LV. Opiates in poppy seed: effect on urinalysis results after consumption
of poppy seed cake-filling. Clin Chem.1987;33:1251-1252.
de Paula M, Saiz LC, Gonzalez-Revalderia J, Pascual T, Alberola C, Miravalles E. Rifampicin causes false-positive immunoassay results for urine opiates. Clin Chem Lab Med.1998;36:241-243.
Hayes LW, Krasselt WG, Mueggler PA. Concentrations of morphine and codeine in serum and urine after ingestion
of poppy seeds. Clin Chem.1987;33:806-808.
Council on Scientific Affairs. Scientific issues in drug testing. JAMA.1987;257:3110-3114.
Sloop G, Hall M, Simmons GT, Robinson CA. False-positive postmortem EMIT drugs-of-abuse assay due to lactate
dehydrogenase and lactate in urine. J Anal Toxicol.1995;19:554-556.
Herrera Trevilla P, Ortiz Jimenez E, Tena T, Lora Tamayo C. Presence of rifampicin in urine causes cross-reactivity with opiates
using the KIMS method. J Anal Toxicol.1995;19:200.
Karabalut N. Pharamacokinetics and quinolones. In: Hooper DC, Wolfson JS, ed. Quinolone Antimicrobial
Agents. Washington, DC: American Society for Microbiology; 2000:202-204.
The choice of antibacterial drugs. Med Lett Drugs Ther.1998;40:33-42.
Centers for Disease Control and Prevention. 1998 guidelines for treatment of sexually transmitted diseases. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep.1998;47:1-111.
Bartlett JG, Breiman RF, Mandell LA, File TM. Community-acquired pneumonia in adults: guidelines for management. Clin Infect Dis.1998;26:811-838.
Kohno S, Koga H, Kaku M.
et al. Prospective comparative study of ofloxacin or ethambutol for the treatment
of pulmonary tuberculosis. Chest.1992;102:1815.
Yew WW, Kwan SY, Ma WK.
et al. In-vitro activity of ofloxacin against Mycobacterium
tuberculosis and its clinical efficacy in multiply resistant pulmonary
tuberculosis. J Antimicrob Chemother.1990;26:227.
File TM, Segreti J, Dunbar L.
et al. A multicenter, randomized study comparing the efficacy and safety of
intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime
axetil in treatments of adults with community-acquired pneumonia. Antimicrob Agents Chemother.1997;41:1965.
Small PM, Fujiwara PI. Management of tuberculosis in the United States. N Engl J Med.2001;345:189-200.
Tahaoglu K, Torun T, Sevim T.
et al. The treatment of multidrug-resistant tuberculosis in Turkey. N Engl J Med.2001;345:170-174.
Drugs and vaccines for biological weapons. Med Lett Drugs Ther.2001;43:87-89.
Inglesby TV, Henderson DA, Bartlett JG.
et al. for the Working Group on Civilian Biodefense. Anthrax as a biological weapon: medical and public health management. JAMA.1999;281:1735-1745.
elSohly HN, Stanford DF, Jones AB, elSohly MA, Snyder H, Pedersen C. Gas chromatographic/mass spectrometric analysis of morphine and codeine
in human urine of poppy seed eaters. J Forensic Sci.1988;33:347-356.
Paul B, Mell L, Mitchell J, Irving J, Novak A. Simultaneous identification and quantitation of codeine and morphine
in urine by capillary gas chromatography and mass spectroscopy. J Anal Toxicol.1985;9:222-226.